Question follow-through · 32594
Pancreatic Enzyme Replacement Therapy: Drugs
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the availability of Pancreatic Enzyme Replacement Therapy (PERT) drugs; and if he will take steps to tackle shortages.
About this written question
A written question asks a government minister for information in writing. Parliament publishes the question and any answer.
- Answering body
- Department of Health and Social Care
- Tabled
- 21 Feb 2025
- Target answer date
- 25 Feb 2025
- Answer
- 27 Feb 2025 · 6 calendar days after tabling
Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.
More questions by this MP on Health and care
- Hospices: Finance · 24 Feb 2025
- Hospices: Standards · 25 Feb 2025
- Hospices: Finance · 25 Feb 2025
- Hospices: Charitable Donations · 25 Feb 2025
- Prescriptions: Fees and Charges · 27 Feb 2025
Shared topic keywords suggest a connection; they do not establish a follow-up.
Votes on this topic
- Terminally Ill Adults (End of Life) Bill: Second Reading · 11 Sept 2026
- Health Bill: Report Stage: Amendment 1 · 8 Sept 2026
- Health Bill: Report Stage: New Clause 143 · 8 Sept 2026
These Commons divisions share a topic label. The question did not necessarily lead to a vote.
Recorded timeline
21 Feb 2025
Question tabled
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the adequacy of the availability of Pancreatic Enzyme Replacement Therapy (PERT) drugs; and if he will take steps to tackle shortages.
25 Feb 2025
Target answer date
Date supplied by the official written-questions record.
27 Feb 2025
Answer published
The Department monitors and manages medicine supply at a national level so that stocks remain available to meet regional and local demand. Information on stock levels within local areas is not held centrally.The Department is continuing to engage with all...
Official data retrieved 28 Sept 2026.
Later records
Possible follow-up questions
Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.
Hospices: Finance
24 Feb 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 January 2025 to Question 21470 on Hospices: Charitable Donations, if he will provide financial support to hospices to directly cover declining charitable incomes.
Hospices: Standards
25 Feb 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 January 2025 to Question 21470 on Hospices: Charitable Donations, whether his Department has made an assessment of the potential implications for its policies of recent
Hospices: Finance
25 Feb 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 January 2025 to Question 21470 on Hospices: Charitable Donations, what proportion of the recently announced investment for hospices has been allocated; and how much has
Hospices: Charitable Donations
25 Feb 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 8 January 2025 to Question 21470 on Hospices: Charitable Donations, what steps his Department is taking to monitor the potential impact of declining charitable income on h
Prescriptions: Fees and Charges
27 Feb 2025 · To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that prescription charges do not act as a barrier to treatment for people with long-term medical conditions.
Rare Diseases: Research
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, if he will take steps to strengthen the Orphan drug regulations to encourage research into rare diseases.
Rare Cancers: Clinical Trials and Research
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to ensure patients can (a) get better access to and (b) find out about (i) research and (ii) clinical trials for rare cancers.
Rare Cancers: Research
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, if he will appoint a named lead in the Department with a responsibility to support research and innovation for rare cancers.
Prescriptions: Fees and Charges
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the potential impact of the level of NHS prescription charges on (a) patients' health outcomes and (b) numbers of (i) hospital admissions and (ii) GP visits
Prescriptions: Fees and Charges
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, whether his Department has make an assessment of the potential merits of reviewing the prescription charge exemption list to increase the support for patients with chronic illness.
Prescriptions: Fees and Charges
28 Feb 2025 · To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of prescription charges on patients with long-term health conditions; and whether he has made an estimate of the number individuals not taking pr
NHS: Pilot Schemes
5 Mar 2025 · To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of requiring the NHS to offer pocket-sized trauma cards for patients to show during appointments.